TDF clinical trials

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

This study looks at a new drug, ALG-000184, for chronic hepatitis B. It compares it with an existing treatment, tenofovir, to see how safe and effective it is over 48 weeks. It's for adults who haven't been treated for hepatitis B before.